HELP
Cybin Inc
NASDAQ · Pharmaceuticals
$5.98
+0.12 (+2.05%)
Open$6.00
Previous Close$5.86
Day High$6.24
Day Low$5.80
52W High$10.87
52W Low$4.36
Volume—
Avg Volume276.0K
Market Cap1.92M
P/E Ratio—
EPS$-1.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+62.5% upside
Current
$5.98
$5.98
Target
$9.72
$9.72
$6.32
$9.72 avg
$10.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 493.3K | 481.3K | 473.6K |
| Net Income | 115.4K | 80.6K | 101.2K |
| Profit Margin | 23.4% | 16.8% | 21.4% |
| EBITDA | 189.6K | 155.0K | 161.9K |
| Free Cash Flow | 102.8K | 100.3K | 125.4K |
| Rev Growth | +17.7% | -1.9% | +10.9% |
| Debt/Equity | 0.11 | 0.15 | 0.11 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |